-transparent.png){kind=logo}
Skeletal demineralisation was measured for two years in 16 patients on maintenance haemodialysis; the technique employed was neutron activation analysis of a hand. The magnesium concentration of the dialysate was increased in six of the patients; oral calcium carbonate was administered to seven patients and 1-alpha-hydroxycholecalciferol, a potent vitamin-D analogue was supplied to a further three patients. An increase in skeletal calcium content of a hand was noted in the groups of patients receiving supplementary calcium and 1-alpha-hydroxycholecalciferol. It is concluded that 1-alpha-hydroxycholecalciferol appears to be effective therapy for renal osteodystropy, that oral calcium supplements may promote skeletal remineralisation and that supplementary magnesium therapy may reduce the progressive losses of skeletal calcium from some patients on maintenance haemodialysis.
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
October 1996,
Pediatric nephrology (Berlin, Germany),
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
November 1966,
Annals of internal medicine,
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
March 1978,
Nederlands tijdschrift voor geneeskunde,
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
January 1973,
The Netherlands journal of medicine,
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
January 1984,
Hormone research,
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
December 1985,
The American journal of the medical sciences,
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
January 1961,
The Quarterly journal of medicine,
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
October 1974,
Die Medizinische Welt,
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
January 2003,
Blood purification,
G R Catto, and
M MacLeod, and
B Pelc, and
E Kodicek
January 1985,
Vutreshni bolesti,
